Loading…
Saroja Pharma Industries India (SAROJA)₹40.00+3.09%Specialty Chemicals
At the end of the Mar 2026 quarter, Saroja Pharma Industries India's shareholders were: promoters 72.99%, public 27.01%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 414 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Promoters | 72.99% | 72.99% | 72.99% | 72.99% | 72.99% | 72.99% |
| Public | 27.01% | 27.01% | 27.01% | 27.01% | 27.01% | 27.01% |
| Promoter shares pledged | — | — | — | — | — | 0.00% |
| Number of shareholders | 598 | 507 | 439 | 423 | 436 | 414 |
| Holder | Category | Mar 2026 | Change (pp) |
|---|---|---|---|
| Biju Gopinathan Nair | Promoter | 72.11% | — |
| Swastika Investmart Ltd | Public | 2.00% | — |
| Kamlesh Natwarlal Shah | Public | 1.30% | — |
| Manish Dasharath Kamble | Promoter | 0.98% | — |
Promoters held 72.99% of Saroja Pharma Industries India at the end of the Mar 2026 quarter, the same as a year earlier.
No. The Mar 2026 filing shows no pledged promoter shares.
Saroja Pharma Industries India had 414 shareholders at the end of the Mar 2026 quarter, against 507 a year earlier.
Swastika Investmart Ltd (Public) held 2.00% at the end of the Mar 2026 quarter, the largest named holding outside the promoter group.